Fusion oncoproteins, such as those that cause the rare cancer Ewing sarcoma, are promising targets for new cancer drugs. However, the nature of these abnormal molecules poses challenges in drug ...

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment ...

Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...